Adverse Immune Effects of Nanomedicines and Biologicals– Under the Microscope
Add bookmark
Adverse Immune Effects of Nanomedicines and Biologicals– Under the Microscope
Add bookmark
Janos Szebeni, Director of the Nanomedicine Research and Education Center, Bay Zoltan Foundation for Applied Research at Semmelweis University, Budapest, joins Helen Winsor Pharma IQ, to discuss developments in immunogenicity. In this exclusive interview, Szebeni talks about the aims of his current research and how this will affect our current understanding of immunogenicity. He outlines the main challenges faced and the best practice methods that have been put in place to overcome these setbacks.
[inlinead]
Tags:
Janos Szebeni
Semmelweis University
immunogenicity
adverse immune effects
nanomedicines
Biologicals
